Comentarios del lector/a

oligometastatic disease

por Mia Ryan (2018-05-08)

A prospective study from the University of Rochester showed that in 40 patients with oligometastatic breast cancer treated with curative intent SBRT to five or fewer sites had a 59% 4-year overall survival and 38% progression-free survival. Get assignment help on this prospective study